by admin | Sep 15, 2021
Entrepreneurial Lead of the NuclearMediX team and Postdoctoral Researcher at Imperial College London. Dr. Fu has extensive experience in drug development, from lead selection to pre-clinical stages. He specializes in developing and managing novel radioconjugates of...
by admin | Sep 15, 2021
Principal Scientific Advisor of NuclearMediX and inventor of the Fluoroethyl-triazole Octreotate ([18F]FET-βAG-TOCA, FETO) SSTR-PET tracer. Prof. Aboagye is a Fellow of the Academy of Medical Sciences (FMedSci) and Professor of Cancer Pharmacology & Molecular...
by admin | Sep 15, 2021
Dr. Spruce holds a PhD in Molecular Biology and Oncology and has over 10 years of experience as an academic. With formal training and experience in technology transfer, she supports the Faculty of Medicine in assessing research discoveries for commercial potential and...
